AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimibeat-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Life Drug Pharmaceutical

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimibeat-M1 Tablet SR

Diabexe Duo SR tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Diabexe Duo SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications including kidney disease, vision loss, neuropathy, and limb amputation. Remember, Diabexe Duo SR is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular eating habits and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabexe Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician before starting this medication. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Glimibeat-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimibeat-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimibeat-M1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Glimibeat-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibeat-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimibeat-M1 Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Take it with food.

How Glimibeat-M1 Tablet SR works:

Glimibeat-M1 SR tablets contain a dual-action formulation of glimepiride and metformin, both used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimibeat-M1 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimibeat-M1 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescription. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimibeat-M1 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimibeat-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimibeat-M1 Tablet SR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimibeat-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate Glimibeat-M1 Tablet SR therapy at a low dose; its use is contraindicated in severe liver disease.

What if you forget to take Glimibeat-M1 Tablet SR :

Should you forget a Glimibeat-M1 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimibeat-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimibeat-M1 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimibeat-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimibeat-M1 Tablet SR and seek immediate medical attention.
Glimibeat-M1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimibeat-M1 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimibeat-M1 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Glimibeat-M1 Tablet SR can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimibeat-M1 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimibeat-M1 Tablet SR
57
MRP 70
18% off